Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Thrombocytopenia
Related studies linked through entity extraction aliases.
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
- Status
- COMPLETED
- Phase
- PHASE3
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
- Status
- COMPLETED
- Phase
- PHASE3
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE3
Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
- Status
- COMPLETED
- Phase
- N/A
Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
- Status
- COMPLETED
- Phase
- PHASE3
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
- Status
- COMPLETED
- Phase
- PHASE3
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
- Status
- COMPLETED
- Phase
- PHASE3
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
- Status
- COMPLETED
- Phase
- PHASE3
Daclizumab to Treat Chronic Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
- Status
- COMPLETED
- Phase
- PHASE4